On ECHEMI
Home > Drugs > Yunnan Yufeng Pharmaceutical Co., Ltd.
Yunnan Yufeng Pharmaceutical Co., Ltd.
  • Founded in:

    2018-01-09
  • Country:

    China China
  • Address:

    Zhuangdian Medical Area, Chuxiong Development Zone, Yunnan Province
  • Tax NO.:

    91532300MA6MY5XD30
  • Registered Funds:

    62.2 million yuan
  • Website:

  • Email:

Related Drugs
Banxialu Granules
Raw pinellia, loquat leaves, polygala (soaked), coltsfoot flowers, platycodon, ephedra, licorice, tangerine peel, and peppermint oil.
Name Description Content CAS NO. Registered Holders
Raw Pinellia

0
Loquat leaves

0
Polygala tenuifolia

0
Farfarae Flos

0
Platycodonis Radix

0
Ephedra

0
DGL

0
Citri reticulatae pericarpium

0
Cornmint oil

68917-18-0 1
Sodium Humate Tablets
Sodium humate.
Name Description Content CAS NO. Registered Holders
Sodium humate

0
Sodium Humate Granules
This product is granules made of sodium humate.
Name Description Content CAS NO. Registered Holders
Sodium humate

0
Gegenqinlian tablets
Pueraria root, Scutellaria baicalensis, Coptis chinensis, and roasted licorice.
Name Description Content CAS NO. Registered Holders
Puerariae Lobatae Radix

0
RADIX SCUTELLARIAE

0
COPTIDISRHIZOMA

0
Licorice root flavonoids saponins polysaccharides polyphenols alkaloids volatile oils

0
Fexofenadine Hydrochloride Tablets
The main ingredient of this product is fexofenadine hydrochloride, and its chemical name is plusmn;4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-alpha;,alpha;-dimethylphenylacetic acid hydrochloride.
Name Description Content CAS NO. Registered Holders
Fexofenadine hydrochloride

An antihistamine with selective peripheral H1 receptor antagonism, inhibiting the release of histamine from peritoneal mast cells, without anticholinergic, alpha;1-adrenergic or beta;-adrenergic receptor blocking effects, without sedation or other central nervous system effects, and cannot cross the blood-brain barrier.

More

An antihistamine with selective peripheral H1 receptor antagonism, inhibiting the release of histamine from peritoneal mast cells, without anticholinergic, alpha;1-adrenergic or beta;-adrenergic receptor blocking effects, without sedation or other central nervous system effects, and cannot cross the blood-brain barrier.

153439-40-8 48
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.